Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex
- 1 May 2004
- journal article
- other
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (9), 644-645
- https://doi.org/10.1016/j.amjmed.2003.11.031
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Valsartan-Induced AngioedemaAnnals of Pharmacotherapy, 2003
- Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapyThe American Journal of Medicine, 2003
- AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in ratsThe FASEB Journal, 2002
- Hereditary AngioedemaArchives of Internal Medicine, 2001
- Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMPHypertension, 2001
- Hereditary angioedema type III: An additional French pedigree with autosomal dominant transmissionJournal of Allergy and Clinical Immunology, 2001
- Drug-Induced Angioedema without UrticariaDrug Safety, 2001
- Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedemaJournal of Allergy and Clinical Immunology, 2000
- Hereditary angioedema with normal C1-inhibitor activity in womenThe Lancet, 2000
- Angioneurotic edema attributed to the use of losartan.Archives of Internal Medicine, 1998